Рубрика
Blog
-
2023
-
ANANDA Scientific announces FDA approval of the IND for a clinical trial exploring treatment of Social Anxiety Disorder (SAD)
-
Invitrx Draws Warning Letter for Unapproved Products
-
AXS-05 Meets Primary End Point in Phase 3 Trial of Alzheimer Agitation
-
Full-Life Technologies Acquires Focus-X Therapeutics
-
FDA Delays Decision Date on Gamida Cell BLA
-
C4X Discovery shares jump after it signs AstraZeneca deal worth up
-
FDA Grants Fast Track to Palisade Bio’s Drug Candidate
-
Chemotherapy could increase disease susceptibility in future generations
-
Chemotherapy could increase disease susceptibility in future generations
-
Senators Introduce New Bill to Promote Research and Access to MDMA, Psilocybin